Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001076809-25-000098·GLAZER CAPITAL, LLC
Schedule 13G ownership disclosure
Y-MABS THERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 984241109
Event date: 2025-08-08
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Glazer Capital, LLC
Shares: 2,654,700.00 · Class: 5.84%
- Paul J. Glazer
Shares: 2,654,700.00 · Class: 5.84%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001076809-25-000098
- Form type
- SCHEDULE 13G
- Filer
- GLAZER CAPITAL, LLC
- CIK
- CIK 1076809
- Filed
- Aug 15, 2025
- Reporting period
- Aug 08, 2025
- Description
- Schedule 13G beneficial ownership